title: [Immediate or delayed postoperative radiotherapy in prostate cancer].
abstract: Relapse after radical prostatectomy is strongly correlated with clinical stage, Gleason score and surgical margins. Adjuvant radiotherapy for high-risk group seems to be the best treatment and final results of EORTC will give definitive response. Regarding biological relapses, radiotherapy allows a cure rate of 50% if this treatment begins promptly after raising PSA. The role of concomitant hormonotherapy is still pending waiting for the results of the new AFU/GETUG protocol.
authors.affiliation: Département de radiothérapie, centre Léon-Bérard, 28, rue Laënnec, 69008 Lyon, France. carrie@lyon.fnclcc.fr
authors.forename: Christian
authors.initials: C
authors.lastname: Carrie
authors.forename: Pascal
authors.initials: P
authors.lastname: Pommier
mesh_terms: D019583:Dose Fractionation, Radiation; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D018714:Radiotherapy, Adjuvant; D012307:Risk Factors; D013997:Time Factors
chemical_list: D017430:Prostate-Specific Antigen